Pfizer: COVID-19 Pill Effective in High-Risk Cases
COVID-19 antiviral pill is effective by y 89% in high-risk cases, the US company
Britain Becomes First Country to Approve COVID-19 Pill
Britain has approved COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Thus,
EMA Starts Review Of Merck Oral Covid Drug
The European Medicines Agency (EMA) has started on Monday a review of a potentially
